Literature DB >> 10993859

Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study.

S F Yiu1, M Enriquez-Sarano, C Tribouilloy, J B Seward, A J Tajik.   

Abstract

BACKGROUND: Functional mitral regurgitation (FMR) occurs with a structurally normal valve as a complication of systolic left ventricular dysfunction (LVD). Determinants of degree of FMR are poorly defined; thus, mechanistic therapeutic approaches to FMR are hindered. METHODS AND
RESULTS: In a prospective study of 21 control subjects and 128 patients with LVD (defined as ejection fraction <50%, mean 31+/-9%) in sinus rhythm, we quantified simultaneously by echocardiography the effective regurgitant orifice (ERO) of FMR by using 2 methods: mitral deformation (valve and annulus) and left ventricular (LV) global (volumes, stress, function, and sphericity) and local (papillary muscle displacements and regional wall motion index) remodeling. A wide range of ERO (15+/-14 mm(2), 0 to 87 mm(2)) was observed, unrelated to ejection fraction (P:=0.32). The major determinant of ERO was mitral deformation, ie, systolic valvular tenting and annular contraction in univariate (r=0.74 and r=-0.61, respectively; both P:<0.0001) and multivariate (both P:<0. 0001) analyses, independent of global LV remodeling. Systolic valvular tenting was strongly determined by local LV alterations, particularly apical (r=0.75) and posterior (r=0.70) displacement of papillary muscle, with confirmation in multivariate analysis (both P:<0.0001), independent of LV volumes, function, and sphericity.
CONCLUSIONS: The presence and degree of FMR complicating LVD are unrelated to the severity of LVD. Local LV remodeling (apical and posterior displacement of papillary muscles) leads to excess valvular tenting independent of global LV remodeling. In turn, excess tenting and loss of systolic annular contraction are associated with larger EROs. These determinants of FMR warrant consideration for specific approaches to the treatment of FMR complicating LVD.

Entities:  

Mesh:

Year:  2000        PMID: 10993859     DOI: 10.1161/01.cir.102.12.1400

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  112 in total

Review 1.  Timing of mitral valve surgery.

Authors:  Maurice Enriquez-Sarano
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Mechanistic insights into functional mitral regurgitation.

Authors:  Robert A Levine; Judy Hung; Yutaka Otsuji; Emmanuel Messas; Noah Liel-Cohen; Nadia Nathan; Mark D Handschumacher; J Luis Guerrero; Shengqiu He; Ajit P Yoganathan; Gus J Vlahakes
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

Review 3.  Trends in the surgical management of ischemic mitral regurgitation.

Authors:  Chad E Hamner; Thoralf M Sundt
Journal:  Curr Cardiol Rep       Date:  2003-03       Impact factor: 2.931

4.  The unique mechanism of functional mitral regurgitation in acute myocardial infarction: a prospective dynamic 4D quantitative echocardiographic study.

Authors:  Toshiyuki Kimura; Véronique L Roger; Nozomi Watanabe; Sergio Barros-Gomes; Yan Topilsky; Shun Nishino; Yoshisato Shibata; Maurice Enriquez-Sarano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-04-01       Impact factor: 6.875

Review 5.  Management of ischaemic mitral regurgitation.

Authors:  Bernard Iung
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

Review 6.  Assessment of mitral regurgitation.

Authors:  T Irvine; X K Li; D J Sahn; A Kenny
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

7.  Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.

Authors:  Alessandra Meris; Maria Amigoni; Anil Verma; Jens Jakob Thune; Lars Køber; Eric Velazquez; John J V McMurray; Marc A Pfeffer; Robert Califf; Robert A Levine; Scott D Solomon
Journal:  J Am Soc Echocardiogr       Date:  2012-02-04       Impact factor: 5.251

8.  Persistence of mitral regurgitation following ring annuloplasty: is the papillary muscle outside or inside the ring?

Authors:  Judy Hung; Jorge Solis; Mark D Handschumacher; J Luis Guerrero; Robert A Levine
Journal:  J Heart Valve Dis       Date:  2012-03

Review 9.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

10.  Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy-The BIOCRT Study.

Authors:  Jonathan Beaudoin; Jagmeet P Singh; Jackie Szymonifka; Qing Zhou; Robert A Levine; James L Januzzi; Quynh A Truong
Journal:  Can J Cardiol       Date:  2016-06-02       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.